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Abstract 
Effects of Prolonged Sitting and Walking for Two Days on Postprandial 
Triglycerides in Men: Interaction with Energy Intake 
 
Sanghee Park, M.S.Kin 
The University of Texas at Austin, 2011 
 
 
Supervisor: Edward F. Coyle 
Postprandial hypertriglyceridemia (PPHT), an independent risk factor for atherosclerosis 
(Smyth and Heron 2006; Nordestgaard, Benn et al. 2007), is strongly associated with 
metabolic syndrome and cardiovascular diseases (CVD) (Kolovou, Anagnostopoulou et 
al. 2005). It has been proposed that elevated triglycerides after a high-fat meal may be a 
postprandial phenomenon (Zilversmit 1979). PPHT are commonly concurrent with 
sedentary behaviors, such as extended sitting, which amplify PPHT (Levine, Vander Weg 
et al. 2006). The purpose of this study was to examine the effects of prolonged sitting 
with or without a balanced caloric diet and walking with a balanced diet on postprandial 
triglycerides (PPTG). Seven healthy, young men (age, 25.6 ± 3.7 y; height, 174 ± 5 cm; 
weight, 71.4 ± 6.2kg; VO2max, 49.3 ± 7.7 ml/kg/min) were recruited from a college and 
from within the Austin community. After 2 days of food and activity control (D1and D2), 
subjects performed one of three trials in a randomized, cross-over design for 2 days (D3 
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and D4); (1) active walking with a balanced diet (WB), (2) prolonged sitting with a 
hyper-caloric diet (SH), and (3) prolonged sitting with a balanced diet (SB). High fat 
tolerance tests (HFTT) were conducted on the following day, (D5), after 13 hour over-
night fasting. Blood samples were obtained in the fasting state and every hour for 6 hours 
after subjects had eaten a high fat test meal consisting of 1.2 g fat, 1.1 g CHO, 0.2 g 
protein/kg body mass. All food was provided during the 5-day duration of the study. 
Body postures, heart rate, and daily steps were monitored. In both sit trials (SH and SB), 
subjects sat ~320 minutes longer and took 10 times fewer steps than WB. In WB, the 
total area under the curves for plasma triglycerides (AUCT TG) was lower, compared to 
SH by 21.3% (p<0.001) and to SB by 19.7% (N.S.; p = 0.055), respectively. In WB, the 
incremental AUC TG (AUCI TG), an index of postprandial response, was lower than 
both SH by 17.4% (p <0.005) and SB by 20.1% (p <0.05), respectively. Postprandial 
plasma insulin concentration was lower in WB, compared to SH by 19.4% (p <0.005) in 
AUCT and 18.8 % (p < 0.05) in AUCI. No differences were shown in the metabolic 
responses between SB and SH despite the diet modifications. These findings indicate that 
two days of prolonged sitting significantly amplifies PPTG and suppresses insulin action.      
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In modern societies, humans have become progressively inactive and more exposed to 
high-fat food, increasing the incidence and the risk of obesity and type 2 diabetes 
(Chakravarthy and Booth 2004). Moreover, during most waking periods, people remain 
in non-fasting states, barely staying away from eating for 6-8 hours. Inactive behaviors 
are commonly concurrent with non-fasting states; the combination of the two may 
significantly enlarge the magnitude of plasma triglycerides. Elevation of plasma 
triglycerides in the postprandial state is well associated with the incidence of 
cardiovascular events, atherosclerosis and metabolic syndrome(Nordestgaard, Benn et al. 
2007). In addition, recent epidemiologic studies have shown a positive relationship 
between the time expended on sedentary behaviors and the risk for type 2 diabetes 
mellitus (Hu 2003). However, it is well known that a single bout of moderate exercise 
can significantly reduce PPTG for both untrained and trained individuals (Miyashita, 
Burns et al. 2006; Harrison, O'Gorman et al. 2009), although the attenuating effect is 
transient (~ 60 hours). It has been also shown that increased daily walking has been 
associated with enhancement in health and insulin sensitivity (Stephens, Granados et al.; 
Swartz, Strath et al. 2003), and that brisk walking is effective in attenuating 
PPTG(Miyashita, Burns et al. 2008). Moreover, a growing number of studies have 
 2 
emphasized the beneficial effects of walking and standing to mitigate the detrimental 
effects provoked by a sedentary life style and high-fat diet (Levine, Vander Weg et al. 
2006; Zderic and Hamilton 2006). However, previous studies have yielded mixed results 
on the efficacy of walking in attenuating PPTG (Tsetsonis and Hardman 1996; Katsanos 
and Moffatt 2004). It is generally assumed that non-exercise activities might not be 
controlled during periods of prolonged sitting, which is considered a sedentary behavior. 
Daily variation in non-exercise activity can alter as much as 2,000 kcal/day, implying that 
the control of daily activity can play an important role in determining the effect of true 
daily walking (Levine 2007). Unpublished data in our laboratory verified that both 
moderate exercise and low intensity walking with the careful control of daily activity 
considerably decreased PPTG (40% and 27%, respectively), compared to the true sitting 
control. However, it is unclear whether the effect on PPTG resulted from the energy 
deficit brought on by the caloric expenditure of the exercise or exercise itself. The aim of 
the present study is to examine whether prolonged sitting with a balanced caloric intake 
elevates PPTG, compared to increased walking with balanced energy intake. This study 
also investigates prolonged sitting with a hyper caloric intake, compared to prolonged 









REVIEW OF LITERATURE 
 
INTRODUCTION 
In this review of the literature, pathogenic pathway, insulin action, aerobic exercise and 
daily activity on PPTG are discussed. The present paper focuses on activity control and 
metabolic variables associated with PPTG during active walking or prolonged sitting. 
Daily ambulatory activities for 2 days and metabolic responses on HFTT will be 
emphasized.   
 
PATHOGENIC PATHWAY AND POSTPRANDIAL TRIGLYCERIDES 
Postprandial hypertriglyceridemia is an abnormal elevation in circulating plasma 
triglycerides following a high-fat meal, which  is an independent risk factor for 
atherosclerosis (Nordestgaard, Benn et al. 2007) and an indicator of the risk of 
cardiovascular disease (CVD) (Boquist, Ruotolo et al. 1999). Elevated plasma 
triglycerides in the postprandial state mostly result from small intestine-induced 
chylomicron triglycerides (CM-TG) (i.e., exogenous source) and liver-induced very low 
density lipoprotein triglycerides (VLDL-TG) (i.e., endogenous source) (Goldberg 2009). 
The lipids released from the small intestine and the liver are deposited in peripheral sites, 
such as adipose tissue and skeletal muscle, to be stored as triglycerides or to be utilized as 
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an energy source. Atherogenic potential is amplified by the remnants of CM, VLDL, and 
LDL, which are products of lipoprotein lipase-induced VLDL lipolysis (Lusis 2000). 
These remnants infiltrate the endothelial cells of arteries and lead to the pathogenesis of 
atherosclerosis (Ginsberg and Fisher 2009). Generally, increased PPTG leads to reduced 
plasma HDL and increased small, dense LDL, contributing to the pathogenesis of 
atherosclerosis (Patsch, Esterbauer et al. 2000). There are two sources of triglycerides in 
the blood: exogenous (CM-TG) and endogenous (VLDL-TG). CM-TG is synthesized in 
the epithelial cells of the endoplasmic reticulum (ER) and released into the lymphatic 
system and then circulated through the superior vena cava, while VLDL-TG is produced 
by the ER of hepatocytes (Goldberg 2009).  
 
Exogenous Pathway Dietary triglycerides are broken down by pancreatic lipase into 
monoglyerides and free fatty acids and then absorbed through the enterocytes in the small 
intestine. Free fatty acids and monoglycerides are re-esterified to triglycerides in the ER. 
Before entering the lymphatic systems, triglycerides are lipidated in apolipoprotein B48, 
free cholesterol, cholesterol ester and phospholipid to form CMs (Hussain 2000). CM-TG 
is hydrolyzed by a membrane lipoprotein lipase (mLPL) that is located on the 
endothelium of blood vessel via heparin sulfate-proteoglycans (Oscai, Essig et al. 1990). 
mLPL is the main enzyme responsible for TG hydrolysis and also stimulates the uptake 
of free fatty acids into local tissues. Most free fatty acids are then taken up by adjacent 
tissues, oxidized and re-esterified into triglycerides (Timlin, Barrows et al. 2005). 
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Remnants of CM-TG, produced from CM-TG hydrolyzed by mLPL, is delivered to the 
liver as a primary source for VLDL-TG synthesis (Barrows, Timlin et al. 2005). 
 
Endogenous Pathway On the other hand, VLDL-TG synthesized in the liver with 
apolipoprotein B100 is circulated in the vessels and hydrolyzed by mLPL activity. The 
VLDL-TG hydrolyzed by mLPL creates smaller and denser IDL, which is removed by 
the liver via LDL receptors. Finally, it is broken down into LDL, inducing detrimental 
effects such as atherosclerosis (Ginsberg, Zhang et al. 2005). However, the relationship 
between hypertriglyceridemia and atherosclerosis has remained unclear because the 
development of atherosclerosis is associated with other complex, atherogenic factors such 
as hypertension, insulin resistance and low HDL concentration as well as the presence of 
LDL concentration (Williams and Tabas 2005). The development of atherosclerosis is 
generally initiated by a lesion in the arterial wall, increasing the permeability to 
macromolecules including LDL and apo B-containing lipoproteins such as remnants of 
VLDL-TG and CM-TG. Modified macromolecules stimulate proinflamatory responses 
through lipid oxidation , as a result of reactive oxygen species (ROS). These responses 
eventually contribute to cell death due to scavenger receptor-mediated uptake of the 
macromolecules, leading to a necrotic core in the lesion. Plague ruptures and thrombosis 
occurs, inducing CVD events such as strokes and myocardial infarctions (Ross 1999).  
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INSULIN ACTION AND POSTPRANDIAL TRIGLYCERIDES 
The human body tries to maintain euglycemic homeostasis during resting and exercise. In 
the postprandial state, beta cells of the pancreas release large amount of insulin for the 
maintenance of postprandial glucose concentration. Chronic insulin resistance is an initial 
symptom preceding type 2 diabetes, hyperglycemia and hyperinsulinemia and obesity 
(Petersen, Dufour et al. 2004; Petersen, Dufour et al. 2007). If it disrupts blood glucose 
homeostasis, abnormal elevation of plasma glucose concentration occurs (Olefsky and 
Glass). When skeletal muscle with insulin resistance cannot regulate glucose uptake, the 
liver is prevented from the insulin-induced suppression of hepatic glucose production and 
VLDL assembly and secretion. A growing amount of research has shown that the 
pathogenesis of insulin resistance is significantly correlated with the dysfunction of lipid 
metabolism in skeletal muscle and the liver (Samuel, Petersen et al. 2010). In addition, 
low protein expression of the important enzymes required for oxidative phosphorylation, 
such as pyruvate dehydrogenase, succinate dehydrogenase and cytochrome c oxidase, 
decreases mitochondrial density in insulin resistant offspring of individuals with type 2 
diabetes (Morino, Petersen et al. 2005). Recent studies suggest that the development of 
insulin resistance is significantly related to decreased mitochondria density and function 
for fatty acid oxidation (Hulver, Berggren et al. 2003; Toledo, Menshikova et al. 2007). 
For instance, high fat feeding over 6 months resulted in increased body fat and insulin 
resistance in a low-aerobic capacity mouse model with low expression of proteins 
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including skeletal muscle fatty acid oxidation , despite similar energy intake, compared to 
the high-aerobic capacity group (Noland, Thyfault et al. 2007). This indicates that low fat 
oxidation with a high-fat diet may accumulate body fat, contributing to exacerbating 
insulin action.  
   
AEROBIC EXERCISE AND POSTPRANDIAL TRIGLYCERIDES 
Even though the beneficial effect of exercise is not fully understood, it is well known that 
exercise is a primary contributor to improving metabolic disorders such as hypertension 
and type 2 diabetes (Gill, Al-Mamari et al. 2004; Gill, Al-Mamari et al. 2007). In 
particular, moderate exercise (approximately 50% VO2max) is effective in decreasing 
PPTG (Gill, Herd et al. 2002; Burton, Malkova et al. 2008). However, many factors 
contribute to the magnitude of reduction on PPTG following a single bout of exercise, 
including exercise intensity, duration, type and energy deficit induced by exercise 
(Malkova, Evans et al. 2000; Katsanos, Grandjean et al. 2004). Exercise at 50% VO2max 
over 60 min, for example, reduced PPTG by 9.3%. When exercise duration was extended 
to 120 min at the same intensity, PPTG was reduced by 22.8% (Gill, Herd et al. 2002). 
However, the studies related to the change of exercise type, duration and intensity  have 
shown mixed results. While both continuous and intermittent exercises at a given 
absolute intensity were equally efficient in decreasing PPTG (Miyashita, Burns et al. 
2006; Mestek, Plaisance et al. 2008), some studies showed that only intermittent exercise 
at 60% VO2max (3 × 10 min with 20 min interval between sessions), but not continuous 
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exercise at 60 % VO2max for 30 min, was effective in reducing PPTG, compared to the 
sedentary control group (Altena, Michaelson et al. 2004). In addition, Tsetsonis and 
colleagues showed an equal reduction in PPHG 15 h following completion of either 3 
hours of walking at 30% VO2 max or 90 minutes of energy matched running at 60% VO2 
max (Tsetsonis and Hardman 1996). Conversely, Katsanos and colleagues demonstrated 
that only moderate intensity exercise at 65% VO2 max was effective at improving PPGT 
compared to both energy matched low intensity exercise at 25% VO2 max and a non-
exercise control (Katsanos, Grandjean et al. 2004). These mixed findings are not fully 
understood; however, the discrepant results may be due to the lack of daily activity and 
diet controls. 
    
DAILY ACTIVITY AND POSTPRANDIAL TRIGLYCERIDES 
Total energy expenditure is composed of basal metabolic rate (RMR), the thermal effect 
to food intake, daily activity and structure exercise (Levine 2007). Non-exercise daily 
activity is energy expended through physical activities, such as walking, standing and 
gardening, except for structured exercise (Levine, Eberhardt et al. 1999). Daily walking 
contributes to most of the variation in energy expenditure  of activity thermogenesis in 
humans who do not regularly exercise, implying that increased daily activity is adversely 
associated with increased adiposity (Levine 2007). In addition, daily walking plays a 
crucial role in reducing obesity and obesity related diseases(Levine, Eberhardt et al. 
1999), including insulin resistance, type 2 diabetes, and CVD.  Thus, increasing daily 
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walking is of importance to enhance health (Manson, Greenland et al. 2002; Swartz, 
Strath et al. 2003) whereas the reduction of daily walking contributes to various health-
related metabolic dysfunctions including insulin resistance (Krogh-Madsen, Thyfault et 
al.). A epidemiological study reported that obesity in Britain were increased by 100% 
over 2 decades, based on economic development shifting to a more sedentary lifestyle. 
This shift occurred in spite of decreased energy intake, since decreased energy 
expenditure could contribute to positive energy balance (Prentice and Jebb 1995). 
Conversely, the activation of mLPL, particularly in skeletal muscle, was significant to 
provide resistance to positive energy-induced obesity (Jensen, Schlaepfer et al. 1997). 
The activation of mLPL, which is a key enzyme to hydrolyze triglyceride-rich 
lipoprotein, improves insulin sensitivity and triglyceride metabolism(Zderic and 
Hamilton 2006). Interestingly, slow twitch muscle fibers, mainly activated by ambulatory 
activity (~50%VO2max) (Bey, Akunuri et al. 2003), maximally stimulated m LPL activity 
which was not further increased by vigorous intensity exercise (~110%VO2max) 
(Hamilton, Etienne et al. 1998). However, limited numbers of studies to our knowledge 
have investigated the effect of daily activity on PPTG levels.      




The aim of the present study was to examine the effects of prolonged sitting on PPTG, 
compared to active walking and standing. In particular, the present study focused on 
activity control throughout trials and on metabolic variables in PPTG following 
prolonged sitting or active walking. 









Seven healthy, active male subjects (age of 25.6 ± 3.7 yr, body mass of 71.4 ± 6.2 kg, and 
height of 174 ± 5 cm) were participated in a randomized crossover design. Each subject 
completed all trials. Subjects were allowed to participate only if they were non-smokers 
and normotensive (<140/90 mm Hg), had a BMI of <30 kg/m
2 
with no clinical history of 
cardio-pulmonary and metabolic diseases and took no medications that could affect lipid 
or carbohydrate metabolism. All subjects were fully informed of any possible risks and 
procedures with written informed consent obtained before participation. The study was 
conducted with an ethical approval from the University of Texas Institutional Review 
Board. 
 
STUDY DESIGN  
Three trials were conducted (Figure 1): 1) Increased walking (~17000 daily steps) with 
balanced diet (3156 ± 94 kcal) (WB) (high energy expenditure of 3227 ± 73 kcal) - net 
balance, 2) prolonged sitting (~ 1700 daily steps) with hyper-calories (3156 ±94 kcal) 
(SH) (low energy expenditure of 2525 ± 77 kcal) - energy surplus and 3) prolonged 
sitting (~1700 daily steps) with balanced diet (2528 ± 74 kcal) (SB) (low energy 
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expenditure of 2551± 106 kcal) - net balance. Each subject undertook three intervention 
trials in a randomized, crossover design, each trial occurring for 5 days with one week 
interval between trials. Each subject performed all WB, SH and SB trials. Each trial was 
composed of 3 phases: control (CON) on day 1 (D1) and day 2 (D2), intervention of 
increased walking or prolonged sitting on day 3 (D3) and day4 (D4), and a high fat 
tolerance test (HFTT) on day 5 (D5). Throughout all trials, subjects were instructed to 
refrain from planned exercise. During each 5 day trial, all food was provided from the 
laboratory. The time point subjects ate each meal was recorded for the first trial and 
replicated throughout trials. Provided daily food calories were based on the actual daily 
energy expenditure derived from an activity monitor in preliminary test.  On the HFTT 
day, subjects reported to the laboratory at 0720 following a 13h overnight fast. Body 
weight and height were measured. A catheter was inserted into forearm, followed by a 
fasting blood collection.. After subjects consumed the high-fat meal, they sit quietly 
while working on a computer and watching movies at the end of the HFTT, and blood 
samples were obtained hourly over 6 hours 
 
ACTIVITY CONTROL   
A pedometer (Yamax Digi-Walker SW-200 pedometer; Great Performance Ltd, London, 
United Kingdom) was worn on the waistline of subjects to monitor the daily step 
numbers throughout each trial. To monitor body posture and heart rate on D3 and D4, an 
activity monitor (IDEEA, MiniSun LLC, Fresno, CA) (Zhang, Werner et al. 2003) was 
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installed to the other side of the subjects’ waistline on the evening of D2 until the end of 
each trial. Subjects were instructed to achieve step numbers ~7500 steps per day which is 
regarded as a low level of physical activity (Tudor-Locke and Bassett 2004) and steps 
were evenly distributed throughout the day (~3,000 steps by noon, ~6,000 steps by 5 pm, 
and ~7,500 steps before bed). On D3 and D4, subjects performed the WB, SH, or SB 
intervention. For WB, subjects were asked to evenly step ~17,000 steps during the entire 
day. For SH or SB, subjects were instructed to remain seated throughout much of the day 
and to maintain the daily step numbers ~ 1700 steps per day. During entire trials, subjects 
maintained these diet and physical activity requirements by phone and email 
communication. 
 
HIGH FAT TOLERANCE TEST  
Subjects reported to the laboratory at 0720 in the morning on HFTT day following a 13h-
overnight fast via automobile transportation and consumed each test meal at the same 
time of day in a period no longer than 5 min. Five hundred ml of water was provided to 
subject one hour before the beginning of HFTT. The test meal was prepared, based on 
body mass at 16.1kcal/kg body mass (1119  135 kcal; 1.2, 1.1 and 0.22 g/kg body 
weight of fat, carbohydrate and protein, respectively). Any additional fluids consumed 
during the HFTT were recorded and repeated for the subsequent trials.  
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BIOCHEMICAL ANALYSIS  
All blood samples collected were immediately transferred to K2 EDTA collection tubes 
(BD Vacutainer, Franklin Lakes, NJ), centrifuged at 2,000 g for 15 minutes at 4
°
C.  
Plasma was then stored in separate aliquots at -80
°
C until later analysis. All samples for 
each subject were performed in duplicate within the same run. Plasma triglyceride and 
glucose were measured by a spectrophotometric method using commercially available 
kits (Pointe Scientific, Inc. Canton, USA). Plasma insulin was measured with a 
commercially available human insulin ELISA (Alpco Diagnostics, Salem, USA).  
 
STATISTICAL ANALYSIS  
One-way ANOVA with repeated measures was used to compare mean differences in 
postprandial responses via incremental and the area under the curves(AUC) between 
trials. Insulin resistance was calculated by using the homeostatic model assessment 
(HOMA-IR) and the composite whole body insulin sensitivity index, ISI (composite). 
Fasting plasma TG, glucose, insulin, HOMA-IR, ISI (composite), daily step numbers and 
body positions across trials were analyzed using one-way ANOVA with repeated 
measures. For postprandial TG, glucose, and insulin, two-way ANOVA with repeated 
measures was performed to examine trial and time interaction, followed by post hoc test 








PHYSICAL ACTIVITY AND ENERGY INTAKE CONTROL  
During control days (D1 and D2), there was no difference in step counts across trials 
(~7500 per day). During the treatment days (D3 and D4), subjects stepped 16900 ± 210, 
1631 ± 21 and 1644 ± 20 steps for WB, SH and SB, respectively. Until the end of HFTT 
on D5, step numbers were not different across trials: 518  25, 456  20, and 453  22 for 
WB, SH and SB respectively (Figure 2(A)). According to the 24h-body position analysis 
on D3 and D4 (Figure 2(B)), sitting time was 536  55, 855  41, and 858  59 min for 
WB, SH, and SB, respectively. Sitting time during SH and SB trial was ~320 min longer 
than WB trial (p < 0.001), showing that WB spent significantly less time sitting than SH 
and SB (for all, p < 0.001). Furthermore, walking time was significantly higher in WB 
(131  13 min) than both SH (16  1 min) and SB (16  2 min) (p < 0.001) with no 
difference between SH and SB (Figure 2(B)). During intervention period (D3 and D4), 
time spent standing in WB, SH, and SB (308  66, 97  45 and 111  51 min, 
respectively). Furthermore, sleeping time was not different across trials (449  39, 457  
32, and 441  40 min) (Figure 2(B)). 
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PLASMA CONCENTRATIONS  
In the fasted state, plasma triglycerides were significantly lower in WB by 23% compared 
to SH (p < 0.05) while glucose, and insulin concentrations were not significantly different 
across trials (Figure 4). In the postprandial state, WB reduced AUCT TG by 21.3% 
compared to SH (p < 0.001) and by 19.7% compared to SB (N.S.; p = 0.055). WB 
reduced the AUCI TG, compared to SH by 17.4% (p < 0.005) and SB by 20.1% (p < 
0.05), respectively (Figure 4). The AUCI of plasma glucose was lower in WB than SH by 
50.5%  (p < 0.005) and SB by 49.5% (NS, p = 0.057) (Figure 5). Both AUCT and AUCI 
of plasma insulin were lower in WB, compared to SH by 19.4% and 18.8 (p < 0.005) and 

















The metabolic response to prolonged sitting with hyper or balanced caloric intake was 
measured for 2 days. The key findings of the present study are that prolonged sitting with 
hyper or balanced energy intake, compared to walking with balanced energy intake, 
significantly increased the concentration of postprandial plasma triglycerides and reduced 
whole body insulin action. Prolonged sitting trials, independent of energy intake, equally 
impaired plasma triglycerides, indicating that prolonged sitting has primarily negative 
effects on PPTG. No differences were shown in plasma triglycerides concentration 
between SB and SH despite the diet modifications. These findings indicate that not only 
is daily activity important for enhancing postprandial metabolism, but also that prolonged 
sitting has detrimental consequences on metabolic responses in the concentration of 
plasma triglycerides, independent of energy intake. 
It is well known that increased daily walking improves insulin resistance in humans, 
while prolonged sitting leads to a rapid decrease in insulin action (Stephens, Granados et 
al.; Miyatake, Nishikawa et al. 2002). In addition, recent epidemiological studies reported 
that prolonged sitting increases the risk of metabolic disorders such as obesity and type 2 
diabetes (Fung, Hu et al. 2000; Hu, Leitzmann et al. 2001).  In particular, reduced non-
exercise activity contributes to potential detrimental results on metabolic reactions, 
including insulin resistance (Seider, Nicholson et al. 1982; Hamilton, Hamilton et al. 
Whole body insulin sensitivity 
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2004). In agreement with the present study, previous studies reported that the reduction 
of insulin action was observed following short terms of inactivity intervention in both 
humans and rats (Lipman, Raskin et al. 1972; Ploug, Ohkuwa et al. 1995). Moreover, in 
the postprandial state, a sedentary lifestyle may exacerbate postprandial metabolic 
responses (Nordestgaard, Benn et al. 2007). Ginsberg and colleagues (Ginsberg, Zhang et 
al. 2005) demonstrated that a hyper caloric diet changes energy partitioning, leading to 
liver insensitivity to insulin action. This prevents the liver from suppressing VLDL 
assembly and secretion. The findings of the present study show that insulin action was 
significantly reduced following a short period of prolonged sitting, i.e., 2 days, 
concurrent with an energy surplus (~ 19.4%, p< 0.005), indicating that inactivity with a 
hyper caloric diet may contribute to more detrimental consequences for insulin action. 
Therefore, results of the present study suggest that a hyper caloric diet, in addition to 
prolonged sitting, plays a crucial role in exacerbating acute insulin reactions.  
The result of the present study is quite different from the findings of Stephens et al 
(Stephens, Granados et al.) which demonstrated that prolonged sitting, while maintaining 
an energy surplus for a day, significantly increased the detrimental effects on insulin 
action, compared to prolonged sitting with a balanced caloric diet (p= 0.04). The 
discrepancy of the findings might result from differences in net energy balance, standing 
time, and daily step counts between Stephens et al and the present study (roughly 1000 
kcal vs 600 kcal, 20 min vs 120 min and 264 steps vs 1650 steps per day, respectively). 
This implies that different amount of energy intake and daily activity during prolonged 
sitting may contribute to the discrepant results. In addition, during prolonged sitting, 
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there were significantly higher step counts per day in the present study, compared to 
Stephens findings. This may maintain the activation of slow twitch muscle fibers over a 
certain level since slow twitch muscle fibers, mainly activated by ambulatory activity, 
stimulated m LPL activity in skeletal muscle (Bey, Akunuri et al. 2003). Recent studies 
reported that following 7 days of bed rest, peripheral and whole-body insulin action were 
significantly reduced, even though hepatic insulin sensitivity was not impaired (Mikines, 
Richter et al. 1991; Blanc, Normand et al. 2000). This indicates that skeletal muscle, 
specifically mLPL activity, is a primary candidate for the detrimental effects of inactivity. 
Taken together, reduced muscle activity such as decreased mLPL activity, following 
inactivity plays an important role in lowering metabolic responses. 
From this perspective, the magnitude of the reduced plasma triglyceride concentration in 
WB is robust following 2 days of walking, compared to both SH and SB since increased 
walking in an acute period of time may increase mLPL activity in skeletal muscle. This 
provides an early positive metabolic response to reduce the concentration of plasma 
triglycerides on PPTG, compared to prolonged sitting, independent of energy intake.    
Potential mechanisms for explaining the effects of walking and sitting on PPTG could be 
related to energy redistribution as well as mLPL activity. Walking and standing for 2 
days may contribute to the depletion of hepatic glycogen and triglycerides, causing the 
liver to redistribute energy. When the liver redistributes energy, it induces suppression in 
VLDL production and secretion into the circulation on PPTG. Partitioning of substrates, 
such as remnants of CM and glucose, to the liver is a main factor in determining the 
production and secretion of VLDL-TG (Timlin, Barrows et al. 2005). It is well 
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established that the day following a bout of exercise 3-hydroxybutyrate, an index of 
hepatic triglyceride oxidation, increases in PPTG (Burton, Malkova et al. 2008; Harrison, 
O'Gorman et al. 2009). From this perspective, active walking increases hepatic glycogen 
and triglyceride usage, leading to energy depletion in the liver. Depleted energy in the 
liver may increase hepatic triglyceride oxidation and energy utilization in which VLDL 
production and secretion is reduced, also decreasing plasma TG concentration. However, 
complex mechanisms are likely responsible for increased insulin action and reduced 
plasma triglycerides in response to active walking. Taken together, increased walking 
may induce the depletion of triglycerides and glycogen in the liver and may change 
energy partitioning and utilization in favorable ways in order to reduce the detrimental 
effects on PPTG.   
 A second explanation is that the stimulation of mLPL activity, as a result of active 
walking, may be a primary factor in the improved clearance in PPTG because mLPL is 
the rate limiting enzyme for triglyceride lipolysis on the luminal surface of capillary 
endothelial cells (Oscai, Essig et al. 1990). Kiens et al reported that mLPL activity is 
stimulated in humans even after short-term exercise training (Kiens, Lithell et al. 1989). 
However, this activation is decreased by detraining (Simsolo, Ong et al. 1993) and 
physical inactivity (Hamilton, Hamilton et al. 2004). In this respect, the activation of 
mLPL, to the extent of the present findings, may stimulate walking-modified attenuation 
of PPTG. Therefore, prolonged sitting trials in the present study may reduce mLPL 
activity, which may in turn increase plasma triglyceride concentration by 20% compared 
to walking trial in PPTG. However, Katsanos et al suggested it is unclear whether 
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improved mLPL activity contributes to an walking-induced reduction of PPTG based on 
a finding showing no strong correlation between enhanced mLPL activity and reduction 
in PPTG (Katsanos and Moffatt 2004). More carefully controlled and well-designed 
studies are required in order to improve current understanding of the correlation between 
daily activity, energy intake and metabolic responses. 
In conclusion, the findings of the present study show that prolonged sitting for 2 days can 
decrease insulin action and increase plasma triglyceride concentration in the postprandial 
state. Prolonged sitting with or without a change in energy intake causes the detrimental 
effects on metabolic responses. This implies that other factors besides energy surplus 
may be involved in the process. The results in our study provide evidence for a strong 
relationship between time spent, increased walking and enhanced metabolic health as 
proposed in the tenets describing the inactivity physiology paradigm (Hamilton, 
Hamilton et al. 2007), indicating the importance of maintaining at least daily low-
intensity activity to minimize the harmful effects of physical inactivity on metabolic 
health.  
 
Limitations and Control for Confounding Variables 
The use of young, healthy, non-obese subjects may limit the generalizability of the study 
results to other populations. We chose to study the metabolic responses to prolonged 
sitting in recreationally active, but not highly trained individuals to minimize potential 
confounding effects of disease processes, reported in overweight individuals with low 
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physical activity. Future studies are required to determine if factors such as aging, obesity, 





Figure 1: Experimental protocol 
 
Figure 2: Daily steps (A) and mean distribution of body position (D3-D4) (B) during 
WB, SH and SB trials. *Significantly higher in WB than SH and SB (p<0.005); 
#Significantly lower in WB than SH and SB (p<0.005). Values are expressed as mean ± 
SD. 
 
Figure 3: Daily energy expenditure (A), consumption (B) and net energy balance (C) 
during WB, SH and SB. Intervention periods (D3-D4). *Significantly different from WB; 
#Significantly different from SB; **Significantly different from SH (for all, p<0.001). 
 
Figure 4: Fasting and postprandial plasma triglycerides concentrations before and after 
HFTT over 6 hr (A) and the total and incremental area under the curves (AUC) of plasma 
triglycerides during HFTT (B). Values for AUCs are % of SH. *Significantly  different 
from WB (p<0.05); **from WB (p<0.005).  
 
Figure 5: Plasma glucose concentrations during HFTT over 6 hr. *Significantly  different 
from WB (p<0.05). 
 
Figure 6: Plasma insulin concentrations on HFTT over 6 hr (A). and total and incremental 
AUC of plasma insulin during HFTT (B). Values for AUCs are % of SH. *Significantly  



















































Figure 2(A): Daily steps (D1-D4) during WB, SH and SB trials. *Significantly higher in 


























































Figure 2(B): Mean distribution of body position (D3-D4) during WB, SH and SB trials. 
*Significantly higher in WB than SH and SB (p<0.005); #Significantly lower in 



























Figure 3(A): Daily energy expenditure during WB, SH and SB. Intervention periods 





























Figure 3(B): Daily energy consumption during WB, SH and SB. Intervention periods 


































Figure 3(C): Daily net energy balance during WB, SH and SB. Intervention periods 
(D3-D4). **Significantly higher in SH (p <0.001). 
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Figure 4(A): Fasting and postprandial plasma triglycerides concentrations before and 
after HFTT over 6 hr. Values for AUCs are % of SH. *Significantly  







Figure 4(B): The total and incremental area under the curves (AUC) of plasma 
triglycerides during HFTT. Values for AUCs are % of SH. *Significantly  







Figure 5: Plasma glucose concentrations during HFTT over 6 hr. *Significantly  different 






Figure 6(A): Plasma insulin concentrations on HFTT over 6 hr. *Significantly  different 






Figure 6(B): Total and incremental AUC of plasma insulin during HFTT. Values for AUCs 






MEASUREMENTS OF PLASMA CONCENTRATIONS 
Plasma Triglycerides Measurement 
Plasma triglyceride is measured by a spectrophotometric method using commercially 
available kits (Pointe Scientific, Inc. Canton, USA). The plasma samples are removed 
from freezer (-80°C) and thawed in an ice-water bath. 5ul of plasma sample will be added 
to 300ul of triglyceride reagent. Triglycerides in the sample are hydrolyzed by lipase to 
glycerol and fatty acids. The glycerol is then phosphorylated by ATP to glycerol 3-
phosphate (G-3-P) and ADP in a reaction catalyzed by glycerol kinase (GK). G-3-P is 
then converted to dihydroxyacetone phosphate (DHAP) and hydrogen peroxide in a 
reaction catalyzed by glycerophosphate oxidase (GPO). The hydrogen peroxide then 
reacts with 4-aminoantipyrine and 3-hydroxy-2,4,6-tribomobenzoic (TBHB)in a reaction 
catalyzed by peroxidase to form a red colored quinoneimine dye.  The absorbance of the 
red colored quinoneimine dye is measured spectrophotometrically at 340 nm. The 
intensity of the color produced is directly proportional to the concentration of 







1. TG --- Lipase ---> Glycerol + Fatty Acids 
2. Glycerol + ATP --- GK---> G-3-P + ADP 
3. G-3-P + O2 --- GPO---> DHAP + H2O2 
4. H2O2 + TBHB --- Peroxidase--- > Ouinoneimine dye + 2H2O 
 
Plasma Glucose Measurement: 
Plasma glucose is measured by a spectrophotometric method using commercially 
available kits (Pointe Scientific, Inc. Canton, USA). The plasma samples are removed 
from freezer (-80°C) and thawed in an ice-water bath. 5 uL of plasma sample is added to 
1,000 uL of glucose reagent and then incubated at room temperature for 3 minutes. 
Glucose is phosphorylated with ATP to produce glucose 6-phosphate (G-6-P) in the 
reaction catalyzed by hexokinae (HK). The glucose 6-phosphate is then oxidized with 
concomitant reduction of NAD to NADH in the reaction catalyzed by glucose 6-
phosphate dehydrogenase (G6PDH). The absorbance of NADH formed will be measured 
at 340 nm. The concentration of NADH is directly proportional to the concentration of 
glucose in the sample. 
 
Hexokinae Reaction: 
Reaction 1: Glucose + ATP ---- HK ---> G-6-P + ADP 




Plasma Insulin Measurement: 
The concentration of plasma insulin is determined with a commercially available human 
insulin enzyme-linked immunosorbent assay (Alpco Diagnostics, Salem, USA). The 
assay is a sandwich type immunoassay. The 96 well microplate is coated with a 
monoclonal antibody specific to insulin. The plasma samples are removed from freezer (-
80°C) and thawed in an ice-water bath. 25 uL of plasma sample is transferred to the 
microplate wells. Insulin binds monoclonal insulin primary antibody coated on the well. 
100 uL of enzyme conjugate will be then added to the wells. The microplate is then 
incubated on an orbital imcroplate shaker at 750 rpm for 60 minutes. Enzyme-linked 




 incubation, the wells are then washed with wash buffer and blotted dry. 
Substrate is added and then incubated on an orbital microplate shaker at 750 rpm for 15 
minutes. The substrate reacts with horseradish peroxidase to produce colored products. 
After 2
nd
 incubation, stop solution is added to stop the reaction. The absorbance of insulin 
is measured spectrometrically at 450 nm with reference wavelength of 620 nm. The 
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